Quadrature Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Quadrature Capital's NVS Position: Q1 2026 in Review
Quadrature Capital increased its Novartis (NVS) stake by 154% in Q1 2026, buying an estimated $10.6M and bringing the position to 114,289 shares worth $17.5M. The position accounts for 0.21% of the portfolio, ranked #109.
Quadrature Capital first reported a position in NVS in Q2 2015 and has held it in 5 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Quadrature Capital held 114,289 shares of Novartis worth $17.5M as of Q1 2026.
- Quadrature Capital bought 69,220 Novartis shares in Q1 2026, an estimated $10.6M.
- Novartis made up 0.21% of Quadrature Capital's portfolio in Q1 2026, its #109 holding.
- Quadrature Capital first reported a position in Novartis in Q2 2015 and has held it in 5 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.